A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects

Clinical trial NCT06462118 · COMPLETED

Trial details

NCT number: NCT06462118
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2024-06-17
Primary completion: 2024-10-22
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.